Overview
CHDE Polska is a page describing a project to support an entrepreneur’s financial liquidity. The project is intended to help with current operations after financial difficulties caused by the COVID-19 epidemic. The project value is 82,857.68 PLN.
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2008-01-18. Active
95 2490 0005 0000 4600 2289 0910- 43 2490 0005 0000 4530 8048 3118
27 1240 1792 1787 0010 7715 1147
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $837.8K$837,762 |
Buildings and premises | $285.4K$285,356 |
Properties named as collateral
Nieruchomość w Dąbrowie Górniczej przy ul. Kasprzaka 54a |
Secured liabilities
| Type | Creditor | |
|---|---|---|
Mortgage | ||
Registered pledge | ||
Assignment of receivables |
Public aid
15 public aid cases recorded, with a total value of $3,097,001.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Mar 6, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | Prezes Banku Gospodarstwa Krajowego | |
| Mar 6, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | Prezes Banku Gospodarstwa Krajowego | |
| Mar 6, 2024 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | –– | Prezes Banku Gospodarstwa Krajowego |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2020-08-01 | Dotacja na kapitał obrotowy dla CHDE POLSKA SPÓŁKA AKCYJNA | $21,247$21,247 | Program Operacyjny Polska Wschodnia | |
| 2020-03-01 | Enkapsulacja jako innowacyjna metoda dostarczania lipofilowych substancji czynnych w suplementach diety. | $639.4K$639,404 | Program Operacyjny Inteligentny Rozwój |
Tenders
1 tender recorded as contractor, with a total value of $978.
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Dec 27, 2021 | Dostawa sprzętu medycznego | $978$978 | 10 Wojskowy Szpital Kliniczny z Polikliniką Samodzielny Publiczny Zakład Opieki Zdrowotnej |
Public sector contracts
Chde Polska is the contractor in 16 public sector contracts, worth PLN 15.02k in total. They were signed with 12 public buyers. The largest number (2) were signed with Wojewódzki Szpital Zespolony w Elblągu.
| Public buyer | Value | |
|---|---|---|
| Wojewódzki Szpital Zespolony w Elblągu | PLN 8,600 | |
| Wojewódzki Szpital Specjalistyczny Nr 2 w Jastrzębiu-Zdroju | PLN 356.48 | |
| Uniwersytecki Szpital Kliniczny w Poznaniu | PLN 1,992 | |
| Wojewódzki Szpital Zespolony Im.L.Rydygiera w Toruniu | PLN 203.70 | |
| Samodzielny Publiczny Zakład Opieki Zdrowotnej - Zespół Zakładów | PLN 265.01 |
National Health Fund (NFZ) contracts
Chde Polska has been an NFZ healthcare provider since 2008. In 2017 it is performing 1 contract worth USD 0.00. All its contracts were worth USD 0.00 in total.
NFZ contract value by year (USD)
| Type of care | NFZ branch | Contracts | Value in 2017 |
|---|---|---|---|
| Zaopatrzenie w wyroby medyczne | podkarpackie | 1 | USD 0.00 |
Trademarks
Chde Polska holds 3 active trademarks registered with the Polish Patent Office. 2 marks have expired or were not registered. The first mark was filed in 2010.
| Mark | Protected until | |
|---|---|---|
| GHMS | Apr 15, 2036 | |
| Złoty Standard(word) | Feb 18, 2031 | |
| chde | Dec 20, 2030 | |
| chde NANOPOLYMERS | – | |
| Złoty Standard(word) | – |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
In the case of a one-person management board, a member of the management board is authorised independently to make declarations of will on behalf of the company. If the management board is a multi-member management board, the President of the Management Board is authorised independently to make declarations of will on behalf of the company, and in the case of the remaining members of the management board, two members of the management board acting jointly or one member of the management board acting jointly with a commercial proxy are authorised.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| EMS - Euromed Medical Solutionsp. z o.o. | $21,990,292.06 | euromed.net.pl | ||
| Intimexsp. z o.o. + limited partnership | $18,994,512.90 | intimex.com.pl | ||
| Camedica Paweł Harasimiuksp. k. | $18,691,613.15 | camedica.pl | ||
| Livistosp. z o.o. | $17,956,135.04 | livisto.pl | ||
| OwlieS.A. | $17,199,251.89 | owlie.pl | ||
| Ivoclar-Vivadent Polskasp. z o.o. | $17,154,419.26 | ivoclar.com | ||
| Biochem PolskaS.A. | $13,180,007.81 | biochempolska.pl | ||
| AO East Europesp. z o.o. | $13,998,610.57 | aoeasteurope.pl | ||
| Simedusp. z o.o. | $13,968,807.31 | simedu.pl | ||
| MED Partner Marszałeksp. k. | $5,739,702.56 | med-partner.pl |
FAQ
Last updated: 2026-10-02